NK cells (Qilu Cell Therapy)

NK细胞（齐鲁细胞）

Report date: 2025/04/02 13:36:23

Base Information

Drug NameNK cells (Qilu Cell Therapy)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cell replacementsNatural killer cell receptors modulators
TargetsNatural killer cell receptors
Therapy Area/IndicationsSmall Cell Lung Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShandong Qilu Cell Treapy Engineering&Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Qilu Cell Treapy Engineering&Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A